scispace - formally typeset
M

Michael Karin

Researcher at University of California, San Diego

Publications -  753
Citations -  246120

Michael Karin is an academic researcher from University of California, San Diego. The author has contributed to research in topics: IκB kinase & Signal transduction. The author has an hindex of 236, co-authored 704 publications receiving 226485 citations. Previous affiliations of Michael Karin include Sanford-Burnham Institute for Medical Research & University of California, Los Angeles.

Papers
More filters
Journal ArticleDOI

c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis

TL;DR: The novel JNK inhibitor SP600125 completely blocked IL-1--induced accumulation of phospho-Jun and induction of c-Jun transcription in synoviocytes and in joint arthritis, indicating that JNK is an important therapeutic target for RA.
Journal ArticleDOI

IKK/NF-κB signaling: balancing life and death – a new approach to cancer therapy

TL;DR: Inhibition of IKK-driven NF-kappaB activation offers a strategy for treatment of different malignancies and can convert inflammation- induced tumor growth to inflammation-induced tumor regression.
Journal ArticleDOI

Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus

TL;DR: This work has shown that transcription factors are kept in a latent state in the cytoplasm and are translocated into the nucleus upon activation, where they phosphorylate target transcription factors.
Journal ArticleDOI

The regulation of AP-1 activity by mitogen-activated protein kinases.

TL;DR: The specific roles of three MAPKs, namely ERK, JNK and FRK, in modulation of both the level and activity of AP-1, are discussed.